NCT06838702 Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabolism
| NCT ID | NCT06838702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Osteoporosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-01-11 |
| Primary Completion | 2028-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2023-01-11 with a primary completion date of 2028-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational cohort study offered consecutively to every liver transplant patient who arrives for the first endocrinology visit or returns for follow-up visit for bone metabolism assessment.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years * Patients undergoing liver transplantation for any cause. * Performance of bone densitometry * Performance of examinations pertaining to mineral metabolism * Obtaining informed consent Exclusion Criteria: * none
Contact & Investigator
Uberto Pagotto, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06838702 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06838702 currently recruiting?
Yes, NCT06838702 is actively recruiting participants. Contact the research team at uberto.pagotto@unibo.it for enrollment information.
Where is the NCT06838702 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06838702 clinical trial?
NCT06838702 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Uberto Pagotto, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 150 participants.